CymitQuimica logo

CAS 1643913-93-2

:

Fórmula:C35H29F3N4O3
InChI:InChI=1S/C35H29F3N4O3/c36-28-9-7-24(8-10-28)30-19-26(23-3-5-25(6-4-23)34(44)42-15-13-35(37,38)14-16-42)17-27-18-29(45-33(27)30)21-41-32(43)12-2-22-1-11-31(39)40-20-22/h1-12,17-20H,13-16,21H2,(H2,39,40)(H,41,43)/b12-2+
Chave InChI:MRFOPLWJZULAQD-SWGQDTFXSA-N
SMILES:C1CN(CCC1(F)F)C(=O)C2=CC=C(C=C2)C3=CC(=C4C(=C3)C=C(O4)CNC(=O)/C=C/C5=CN=C(C=C5)N)C6=CC=C(C=C6)F
Foram encontrados 7 produtos.
  • Ref: IN-DA001UUS

    250mg
    A consultar
    1mg
    57,00€
    5mg
    113,00€
    10mg
    142,00€
    25mg
    205,00€
    50mg
    343,00€
    100mg
    656,00€
  • KPT9274

    CAS:
    KPT9274
    Fórmula:C35H29F3N4O3
    Pureza:≥98%
    Peso molecular:610.62

    Ref: 54-BUP05419

    1mg
    89,00€
    5mg
    211,00€
    10mg
    329,00€
    25mg
    525,00€
    50mg
    755,00€
    100mg
    1.015,00€
  • Padnarsertib

    CAS:
    (E)-3-(6-aminopyridin-3-yl)-N-((5-(4-(4,4-difluoropiperidine-1-carbonyl)phenyl)-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide
    Fórmula:C35H29F3N4O3
    Pureza:98%
    Peso molecular:610.63
  • KPT 9274 (ATG-019)

    CAS:
    Fórmula:C35H29F3N4O3
    Peso molecular:610.64

    Ref: 4Z-K-031074

    5mg
    A consultar
    10mg
    A consultar
    25mg
    A consultar
    50mg
    A consultar
    100mg
    A consultar
  • KPT9274

    CAS:
    KPT9274 (PAK4-IN-1) is a non-competitive dual inhibitor of PAK4 and NAMPT(IC50= ~120 nM). It is an orally bioavailable small molecule.
    Fórmula:C35H29F3N4O3
    Pureza:99.01% - 99.93%
    Cor e Forma:Solid
    Peso molecular:610.62

    Ref: TM-T4354

    1mg
    58,00€
    5mg
    137,00€
    1mL*10mM (DMSO)
    178,00€
    10mg
    215,00€
    25mg
    356,00€
    50mg
    512,00€
    100mg
    700,00€
  • KPT9274

    CAS:
    Fórmula:C35H29F3N4O3
    Peso molecular:610.6

    Ref: BE-RMCK020072

    1mg
    120,00€
  • KPT 9274

    CAS:

    KPT 9274 is a molecule that binds to the citric acid cycle effector protein, β-catenin. It has minimal toxicity and is energy-independent. KPT 9274 blocks ATP production by binding to the death protein and inhibits atp production. KPT 9274 has been shown to be effective against high-risk disease such as acute myeloid leukemia (AML). The pharmacokinetic properties of KPT 9274 have been studied in vivo using a rat model. This drug is metabolized by fatty acid oxidation and glucuronidation in the liver and excreted in bile.

    Fórmula:C35H29F3N4O3
    Pureza:Min. 95%
    Peso molecular:610.63 g/mol

    Ref: 3D-FA103866

    1mg
    337,00€
    2mg
    479,00€
    5mg
    709,00€
    10mg
    1.070,00€
    25mg
    1.953,00€